RENAAL- undersøgelsen RENAAL- undersøgelsen (The Reduction of Endpoints in NIDDM with the Angiotensin II Receptor Antagonist Losartan) var en kontrolleret, klinisk verdensomspændende undersøgelse med 1513 type 2- diabetikere med proteinuri, med eller uden hypertension.
34 RENAAL-Study The Reduction of Endpoints in NIDDM with the Angiotensin II Receptor Antagonist Losartan RENAAL study was a controlled clinical study conducted worldwide in 1513 Type 2 diabetic patients with proteinuria, with or without hypertension.